Pfizer cancer med Inlyta wins EU approval; Sanofi, Impax settle patent fight over Genzyme drugs;

 @FiercePharma: Here's more on the 'gutter oil' scandal in China, allegedly used to make antibiotics. Report | Follow @FiercePharma

> Pfizer ($PFE) won European approval for its kidney cancer drug Inlyta as a second-line treatment for a type of advanced kidney cancer. Report

> Impax Laboratories ($IPXL) settled a patent dispute with Sanofi ($SNY) over generic versions of kidney drugs Renvela and Renagel, winning licenses to sell generic versions in 2014. Report

> In the last two months, FDA has lifted bans on the manufacturing faciltiies of several Indian pharma companies, including Sun Pharma, Dr. Reddy's Laboratories and Claris Lifesciences. Report

> Germany's Grunenthal apologized to victims of thalidomide, a drug withdrawn more than 50 years ago after it was found to cause severe birth defects. Report

> The Competition Commission of India is investigating possible "cartelization" of several domestic industries, including pharmaceuticals. Report

Medical Device News

 @FierceMedDev: Watch out, Medtronic, BSX and the rest, researchers have developed a pacemaker that fits on the head of a pin. Story | Follow @FierceMedDev

 @MarkHFierce: So, non-invasive Dx imaging costs for Medicare Part B actually went down from 2006-10. Not so pricey after all. Release | Follow @MarkHFierce

 @DamianFierce: Philips Healthcare's Respironics is conducting its second ventilator recall in as many months. Story | Follow @DamianFierce

> ConvaTec snags catheter maker for $321M. News

> Medicare Dx costs enjoy steady drop. Item

> I-Flow recalls infusion pumps over deadly flaw. News

Biotech News

 @FierceBiotech: Penn grabs Agios deal, settling high-profile IP theft claim. Report | Follow @FierceBiotech

 @JohnCFierce: Offbeat: Pulmatrix's Robert Connelly leaves to helm WikiCell, creating "delicious" food packaging; The startup has Flagship, Polaris backing. Release | Follow @JohnCFierce

> Merck KGaA adds big job cuts, $316M R&D makeover to restructuring plan. More

> Valeant scoops up Medicis' dermatology portfolio in $2.6B buyout. News

> Medivation wins groundbreaking FDA OK for blockbuster prostate cancer drug. Article

Pharma Manufacturing News

> 2 Merck KGaA production facilities whacked in cuts. Article

> Dangers aside, drugmakers can't live without Chinese APIs. Story

Biotech IT News

> Merck Serono bioinformatics head starts new company. Item

> PerkinElmer partners with MGH on informatics system for cancer research. Article

> Video game players take on deadly sepsis for U.S. military. Story

> CLC bio buys molecular docking software company Molegro. News

> Tech startup waltzes with wireless giant in Africa to expand mobile anti-drug counterfeiting system. More

Biotech Research News

> Worm stem cells carry tissue regeneration clues. Report

> Johns Hopkins scientists produce protein that helps track tumors. Item

> Roche/Genentech drug beats back treatment-resistant breast cancer cells. Article

> Cleveland Clinic's Alzheimer's drug makes strong preclinical debut. More

> Gene therapy rebuilds sense of smell in mice. Story

CRO News

> U.K.'s NHS considers commercial services; Big Pharma intrigued. Report

> Hospira drops $200M on Indian API plant. News

> Indian regulator wants to expand its ranks. More

> Charles River snaps up Accugenix for $17M. Story

And Finally... Some 10,000 Yosemite campers may be at risk of hantavirus, the CDC said. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.